Aeglea BioTherapeutics, Inc. Gains 61.4%

Fri, Oct 28, 2022 at 07:31 PM
Aeglea BioTherapeutics, Inc. Gains 61.4%

Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ) shot up at $0.92, a gain of 61.4%. On Fri, Oct 28, 2022, AGLE:NASDAQ touched a New 2-Week High of $0.92. The stock got featured on our News Catalysts scanner on Fri, Oct 21, 2022 at 02:50 PM in the 'ACQUISITION' category. From Fri, Oct 14, 2022, the stock recorded 50.00% Up Days and 63.64% Green Days

About Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ)

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.